All Stories

  1. The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its Catabolites
  2. The interplay between mentalization, personality traits and burnout in psychiatry training: Results from a large multicenter controlled study
  3. Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis
  4. Acute stress symptoms in general population during the first wave of COVID lockdown in Italy: Results from the COMET trial
  5. Influence of intrinsic and extrinsic religiosity on youth cannabis use: A structural equation modelling analysis on national survey on drug use and health (NSDUH) 2015–2019
  6. The impact of MDQ positivity on quality of life impairment: Does it support the hypothesis of “Dysregulation of Mood, Energy, and Social Rhythms Syndrome” (DYMERS)?
  7. The effect of social media and infodemic on mental health during the COVID-19 pandemic: results from the COMET multicentric trial
  8. Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates
  9. The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses
  10. Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
  11. Characterizing the clinical profile of mania without major depressive episodes: a systematic review and meta-analysis of factors associated with unipolar mania
  12. Anterior pituitary hormones in first-episode psychosis: a systematic review and meta-analysis
  13. Clinical factors associated with unipolar mania: A systematic review and meta-analysis
  14. Mental health and COVID-19 in university students: a qualitative study comparing Italy and the UK
  15. Mental Health and COVID-19 in University Students: Findings from a Qualitative, Comparative Study in Italy and the UK
  16. Blood concentrations of neopterin and biopterin in subjects with depression: A systematic review and meta-analysis
  17. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
  18. Effect of long-acting injectable antipsychotics on emergency department visits and hospital admissions in people with bipolar disorder: A retrospective mirror-image analysis from the Northern Milan Area Cohort (NOMIAC) study
  19. Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
  20. Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study
  21. A Pan-European Review of Good Practices in Early Intervention Safeguarding Practice with Children, Young People and Families: Evidence Gathering to Inform a Multi-disciplinary Training Programme (the ERICA Project) in Preventing Child Abuse and Neglect...
  22. Use of social network as a coping strategy for depression among young people during the COVID-19 lockdown: findings from the COMET collaborative study
  23. Psychotropic drug purchases during the COVID-19 pandemic in Italy and their relationship with mobility restrictions
  24. Appetite-regulating hormones in bipolar disorder: A systematic review and meta-analysis
  25. Insomnia and related factors in patients with pre-existing psychiatric disorders compared to the general population during the COVID-19 lockdown: Findings from the multicentric COMET study
  26. Innovations in community-based mental health care: an overview of meta-analyses
  27. Testing the Impact of Depressive and Anxiety Features on the Association between Attention-Deficit/Hyperactivity Disorder Symptoms and Academic Performance among University Students: A Mediation Analysis
  28. Psychopathological burden and coping strategies among frontline and second-line Italian healthcare workers facing the COVID-19 emergency: Findings from the COMET collaborative network
  29. Were anxiety, depression and psychological distress associated with local mortality rates during COVID-19 outbreak in Italy? Findings from the COMET study
  30. Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: A meta-analysis
  31. Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study
  32. Focus on Peripheral Biomarkers of Mental Disorders
  33. Influence of positive and negative symptoms on hedonic and eudaemonic well-being in people with schizophrenia: A longitudinal analysis from the EuroSc study
  34. Digital mental health interventions for anxiety and depressive symptoms in university students during the COVID-19 pandemic: A systematic review of randomized controlled trials
  35. Acute psychiatric care: approaches to increasing the range of services and improving access and quality of care
  36. Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study
  37. Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study
  38. Demographic, clinical, and service-use characteristics related to the clinician’s recommendation to transition from child to adult mental health services
  39. Medium and long‐term efficacy of psychoeducational family intervention for bipolar I disorder: Results from a real‐world, multicentric study
  40. COVID-19-Related Social Isolation Predispose to Problematic Internet and Online Video Gaming Use in Italy
  41. Professionals’ Digital Training for Child Maltreatment Prevention in the COVID-19 Era: A Pan-European Model
  42. The impact of Covid-19 on unemployment across Italy: Consequences for those affected by psychiatric conditions
  43. The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
  44. Disentangling the Association between ADHD and Alcohol Use Disorder in Individuals Suffering from Bipolar Disorder: A Systematic Review and Meta-Analysis
  45. The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
  46. Loneliness in Young Adults During the First Wave of COVID-19 Lockdown: Results From the Multicentric COMET Study
  47. Some of us are most at risk: Systematic review and meta-analysis of correlates of depressive symptoms among healthcare workers during the SARS-CoV-2 outbreak
  48. Assessing vulnerability to psychological distress during the COVID-19 pandemic through the analysis of microblogging content
  49. Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis
  50. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
  51. Access to Mental Health Care during the First Wave of the COVID-19 Pandemic in Italy: Results from the COMET Multicentric Study
  52. What Is the Role of Resilience and Coping Strategies on the Mental Health of the General Population during the COVID-19 Pandemic? Results from the Italian Multicentric COMET Study
  53. Family members’ perspectives of child protection services, a metasynthesis of the literature
  54. A longitudinal analysis of a work inclusion model for psychiatric patients in the Mental Health Departments of the city of Milan
  55. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
  56. Longitudinal symptomatic interactions in long-standing schizophrenia: a novel five-point analysis based on directed acyclic graphs
  57. The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites
  58. A Systematic Review of Non-pharmacological Strategies to Reduce the Risk of Violence in Patients With Schizophrenia Spectrum Disorders in Forensic Settings
  59. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
  60. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
  61. Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study
  62. Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
  63. Pharmacological interventions to reduce violence in patients with schizophrenia in forensic psychiatry
  64. Surveilling COVID-19 Emotional Contagion on Twitter by Sentiment Analysis
  65. Did we learn something positive out of the COVID-19 pandemic? Post-traumatic growth and mental health in the general population
  66. Textbook of Addiction Treatment
  67. Pre-Discharge Predictors of 1-Year Rehospitalization in Adolescents and Young Adults with Severe Mental Disorders: A Retrospective Cohort Study
  68. Special Populations: An Introduction
  69. Clinical correlates of DSM-5 mixed features in bipolar disorder: A meta-analysis
  70. The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
  71. Substance use disorders and violent behaviour in patients with severe mental disorders: A prospective, multicentre study
  72. How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist
  73. Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: results from the COMET Collaborative Network
  74. Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
  75. Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels
  76. The Impact of Quarantine and Physical Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric Italian Population Trial
  77. COVID-19 and Substance Use Disorders as Brain Diseases: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper
  78. Cannabidiol for Mood Disorders: A Call for More Research
  79. Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders
  80. Chemokine alterations in bipolar disorder: A systematic review and meta-analysis
  81. Purinergic Signaling and Related Biomarkers in Depression
  82. Detecting Binge Drinking and Alcohol-Related Risky Behaviours from Twitter’s Users: An Exploratory Content- and Topology-Based Analysis
  83. Prescribing Patterns of Psychotropic Drugs and Risk of Violent Behavior: A Prospective, Multicenter Study in Italy
  84. Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
  85. Studying Patients with Severe Mental Disorders Who Act Violently: Italian and European Projects
  86. European violence risk and mental disorders (EU-VIORMED): a multi-centre prospective cohort study protocol
  87. Publisher Correction: Self-harm behaviour and externally-directed aggression in psychiatric outpatients: a multicentre, prospective study (viormed-2 study)
  88. Self-harm behaviour and externally-directed aggression in psychiatric outpatients: a multicentre, prospective study (viormed-2 study)
  89. Personality, Schizophrenia, and Violence: A Longitudinal Study: The Second Wave of the VIORMED Project
  90. Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis
  91. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus
  92. Facial emotion recognition in people with schizophrenia and a history of violence: a mediation analysis
  93. Violence risk and mental disorders (VIORMED-2): A prospective multicenter study in Italy
  94. Ketamine for suicidal ideation treatment: Available evidence remains convincing
  95. Trends of major depressive episode among people with cannabis use: Findings from the National Survey on Drug Use and Health 2006–2015
  96. The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling
  97. Differences in serum uric acid between ‘unipolar’ and ‘bipolar’ depression: Preliminary data
  98. Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling
  99. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis
  100. Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study
  101. Untreated depression and non-medical use of prescription pain relievers: findings from the National Survey on Drug Use and Health 2008-2014
  102. Testing the association of serum uric acid levels with behavioral and clinical characteristics in subjects with major affective disorders: A cross-sectional study
  103. Early Post-stroke Depression and Mortality: Meta-Analysis and Meta-Regression
  104. Facial emotion recognition performance influences executive control impairment in Anorexia Nervosa: an exploratory study
  105. Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015
  106. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
  107. Knowledge and utilization of technology-based interventions for substance use disorders: an exploratory study among health professionals in the European Union
  108. Predicting Young Adults Binge Drinking in Nightlife Scenes
  109. Purinergic system and suicidal behavior: exploring the link between adenosine A2A receptors and depressive/impulsive features
  110. The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study
  111. Insomnia as an additional clinical correlate of suicidal ideation after stroke
  112. Testing the role of the antioxidant uric acid as a biomarker of suicidal ideation in subjects with major affective disorders: An exploratory study
  113. Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis
  114. Antidepressant Response and Dissociative Effects After Ketamine Treatment
  115. Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study
  116. The antioxidant uric acid and depression: clinical evidence and biological hypotheses
  117. Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data
  118. Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met
  119. Social network confidants, duration of untreated psychosis and cannabis use in people with first episode psychosis: An exploratory study
  120. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
  121. Gambling, geographical variations and deprivation: findings from the adult psychiatric morbidity survey
  122. Risk and maintenance factors for young women’s DSM-5 eating disorders
  123. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
  124. Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression
  125. Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
  126. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis
  127. Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis
  128. Purinergic dysfunction in bipolar disorder: Any role for the antioxidant uric acid as a trait and state biomarker?
  129. Association between total serum cholesterol and suicide attempts in subjects with major depressive disorder: Exploring the role of clinical and biochemical confounding factors
  130. Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis
  131. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders
  132. Web- and text-based interventions for smoking cessation: Meta-analysis and meta-regression
  133. Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study
  134. Single and Multiple Clinical Syndromes in Incarcerated Offenders: Associations With Dissociative Experiences and Emotionality
  135. Allopurinol as add-on treatment for mania symptoms in bipolar disorder: Systematic review and meta-analysis of randomised controlled trials
  136. Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?
  137. Agreement between DSM-IV and DSM-5 criteria for alcohol use disorder among outpatients suffering from depressive and anxiety disorders
  138. Stigmatizing Attitudes and Beliefs About Anorexia and Bulimia Nervosa Among Italian Undergraduates
  139. Area-Level Deprivation and Adverse Consequences in People With Substance Use Disorders: Findings From the Psychiatric and Addictive Dual Disorder in Italy (PADDI) Study
  140. Quality assurance in drug demand reduction in European countries: an overview
  141. Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?
  142. Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis
  143. Testing the DSM-5 severity indicator for bulimia nervosa in a treatment-seeking sample
  144. Predicting onset and maintenance of men's eating disorders
  145. Decision support in addiction: The development of an e-health tool to assess and prevent risk of fatal overdose. The ORION Project
  146. Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders
  147. Objectified Body Consciousness (OBC) in Eating Psychopathology
  148. Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment
  149. Dysfunctional bodily experiences in anorexia nervosa: where are we?
  150. First-generation antipsychotics and QTc: any role for mediating variables?
  151. Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe
  152. Exploring the association between bipolar disorder and uric acid: A mediation analysis
  153. Impact of a Mobile E-Health Intervention on Binge Drinking in Young People: The Digital–Alcohol Risk Alertness Notifying Network for Adolescents and Young Adults Project
  154. Body-image distortion in anorexia nervosa
  155. Predictors of initiation and persistence of recurrent binge eating and inappropriate weight compensatory behaviors in college men
  156. Social psychiatry
  157. Prospective Psychosocial Predictors of Onset and Cessation of Eating Pathology amongst College Women
  158. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
  159. Building ties in the community for patients with mental illness
  160. Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis
  161. Disentangling the Association Between Child Abuse and Eating Disorders
  162. Metabolic Syndrome Among People with PTSD: Epidemiological Overview
  163. Feasibility of a psychoeducational family intervention for people with bipolar I disorder and their relatives: Results from an Italian real-world multicentre study
  164. Out of body, out of space: Impaired reference frame processing in eating disorders
  165. Facial emotion recognition in alcohol and substance use disorders: A meta-analysis
  166. Narcissistic Vulnerability and Grandiosity as Mediators Between Insecure Attachment and Future Eating Disordered Behaviors: A Prospective Analysis of Over 2,000 Freshmen
  167. The association between PTSD and metabolic syndrome: A role for comorbid depression?
  168. Posttraumatic Stress Disorder and Risk of Obesity
  169. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study
  170. Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis
  171. E-health app to reduce binge drinking among adolescents and young adults: the D-ARIANNA Project
  172. Benzodiazepine and training
  173. Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses
  174. Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
  175. The Social Appearance Anxiety Scale in Italian Adolescent Populations: Construct Validation and Group Discrimination in Community and Clinical Eating Disorders Samples
  176. A review of regional drug strategies across the world: How is prevention perceived and addressed?
  177. Mechanisms of influence of body checking on binge eating
  178. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders
  179. Facial Emotion Recognition and Disorganization in Subjects with Schizophrenia and Alcohol, Substance Use Disorder
  180. From DSM-IV to DSM-5 alcohol use disorder: An overview of epidemiological data
  181. Efficacy of psychoeducational family intervention for bipolar I disorder: A controlled, multicentric, real-world study
  182. Textbook of Addiction Treatment: International Perspectives
  183. Metabolic Syndrome Among People with PTSD: Epidemiological Overview
  184. Cannabis use disorder as a correlate of suicide attempts among people with bipolar disorder
  185. Special Populations: An Introduction
  186. Psychiatric Comorbidities and Complications of Alcohol and Other Drugs: An Introduction
  187. Comorbid Anxiety and Alcohol or Substance Use Disorders: An Overview
  188. Main Elements of a Systems Approach to Addiction Treatment: An Introduction
  189. Psychotic Disorders and Substance Use Disorders
  190. Testing the cognitive-behavioural maintenance models across DSM-5 bulimic-type eating disorder diagnostic groups: a multi-centre study
  191. The developmental effects of media-ideal internalization and self-objectification processes on adolescents’ negative body-feelings, dietary restraint, and binge eating
  192. Cardiovascular risk factors among people with severe mental illness in Italy: A cross-sectional comparative study
  193. Testing the original and the extended dual-pathway model of lack of control over eating in adolescent girls. A two-year longitudinal study
  194. Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis
  195. Comorbid Addiction and Major Mental Illness in Europe: A Narrative Review
  196. Efforts to make clearer the relationship between body dissatisfaction and binge eating
  197. Risk Estimation Modeling and Feasibility Testing for a Mobile eHealth Intervention for Binge Drinking Among Young People: The D-ARIANNA (Digital-Alcohol RIsk Alertness Notifying Network for Adolescents and young adults) Project
  198. The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis
  199. Attachment insecurities, maladaptive perfectionism, and eating disorder symptoms: A latent mediated and moderated structural equation modeling analysis across diagnostic groups
  200. Prevalence and Correlates of Binge Drinking among Young Adults Using Alcohol: A Cross-Sectional Survey
  201. Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis
  202. Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis
  203. Bipolar Disorder, Schizophrenia, and Metabolic Syndrome
  204. Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
  205. 1882 – The association between post-stroke depression and mortality: a metaanalysis
  206. 1842 – Severe mental illness and metabolic syndrome: a meta-analysis
  207. Perché è importante una federazione europea delle società delle tossicodipendenze?
  208. The association between expressed emotion, illness severity and subjective burden of care in relatives of patients with schizophrenia. Findings from an Italian population
  209. Tossicodipendenze, comorbilità e “doppia diagnosi”
  210. The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC)
  211. Training in Community Psychiatry
  212. Do they actually work across borders? Evaluation of two measures of psychological distress as screening instruments in a non Anglo-Saxon country
  213. MULTIPLE GROUP FAMILY TREATMENT FOR SCHIZOPHRENIA IN ITALY
  214. S14-01 Geographical variations for addiction risk among dually diagnosed people cared in parallel systems
  215. Alcohol Misuse in People with Schizophrenia: Findings from the Paddi (psychiatric and Addictive Dual Diagnosis in Italy) Study
  216. And how shall we deal with adaptation and implementation of NICE schizophrenia guidelines in Italy?
  217. The SIEP-DIRECT's Project on the discrepancy between routine practice and evidence. An outline of main findings and practical implications for the future of community based mental health services
  218. The treatment of acute psychotic episode: discrepancy between routine practice and evidence. The project SIEP-DIRECT's
  219. Promoting recovery of schizophrenic patients: discrepancy between routine practice and evidence. The SIEP-DIRECT's Project
  220. Care across all phases of schizophrenia and initiation of treatment: discrepancy between routine practice and evidence. The SIEP-DIRECT's Project
  221. Management of violent behaviour and rapid tranquillisation during acute psychotic episode: discrepancy between routine practice and evidence. The SIEP-DIRECT's Project
  222. The acceptability of the NICE recommendations for schizophrenia in the Italian Departments of Mental Health. The SIEP-DIRECT's Project on the discrepancy between routine practice and evidence
  223. Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK
  224. Does HIV serostatus affect outcomes of dually diagnosed opiate dependents in residential treatment?
  225. 0188 SOCIAL NETWORKS IN FIRST EPISODE PSYCHOSIS
  226. 0189 SUBSTANCE USE IN FIRST EPISODE PSYCHOSIS
  227. Family interventions for schizophrenia in Italy: randomized controlled trial
  228. Dual Diagnosis—Policy and Practice in Italy
  229. Severity Profiles of Substance-Abusing Patients in Italian Community Addiction Facilities: Influence of Psychiatric Concurrent Disorders
  230. Cesare Lombroso, M.D., 1835–1909
  231. Cesare Lombroso, M.D., 1835-1909
  232. Prevalence of mental disorder and related treatments in a local jail: a 20-month consecutive case study
  233. The Italian Association on Addiction Psychiatry (SIPDip), formerly The Italian Association on Abuse and Addictive Behaviours
  234. Schizofrenia e intervento psicosociale sulle famiglie. Indagine sulle caratteristiche dell'utenza e follow-up ad un anno